All Wales Medicines Strategy Group Final Appraisal Report - Icatibant (Firazyr) for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults (with C1-esterase-inhibitor deficiency).
Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
| Iaith wreiddiol | Saesneg |
|---|---|
| Cyhoeddwr | Unknown |
| Corff comisiynu | NHS Wales |
| Argraffiad | 2008 |
| Statws | Cyhoeddwyd - 1 Ion 2008 |